CLOSTRIDIA DIFFICILE COLITIS

Clinical trials for CLOSTRIDIA DIFFICILE COLITIS explained in plain language.

Never miss a new study

Get alerted when new CLOSTRIDIA DIFFICILE COLITIS trials appear

Sign up with your email to follow new studies for CLOSTRIDIA DIFFICILE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Cheaper antibiotic challenge: can it beat the High-Cost standard for stopping deadly gut infections?

Disease control Not yet recruiting

This study aims to see if a specific, tapering schedule of the antibiotic vancomycin works as well as the standard 10-day course of fidaxomicin to prevent C. difficile infection from coming back. It will enroll 500 adults experiencing their first or second episode of this severe …

Matched conditions: CLOSTRIDIA DIFFICILE COLITIS

Phase: PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

CLOSTRIDIA DIFFICILE COLITIS

Get alerted when new CLOSTRIDIA DIFFICILE COLITIS trials appear

Cheaper antibiotic challenge: can it beat the High-Cost standard for stopping deadly gut infections?